{"id":"https://openalex.org/W2140448647","doi":"https://doi.org/10.1021/ci050008y","title":"3D-QSAR and Docking Studies of Selective GSK-3\u03b2 Inhibitors. Comparison with a Thieno[2,3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3\u03b2 Ligands","display_name":"3D-QSAR and Docking Studies of Selective GSK-3\u03b2 Inhibitors. Comparison with a Thieno[2,3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3\u03b2 Ligands","publication_year":2005,"publication_date":"2005-03-25","ids":{"openalex":"https://openalex.org/W2140448647","doi":"https://doi.org/10.1021/ci050008y","mag":"2140448647","pmid":"https://pubmed.ncbi.nlm.nih.gov/15921460"},"language":"en","primary_location":{"id":"doi:10.1021/ci050008y","doi":"https://doi.org/10.1021/ci050008y","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ci050008y","pdf_url":null,"source":{"id":"https://openalex.org/S167262187","display_name":"Journal of Chemical Information and Modeling","issn_l":"1549-9596","issn":["1549-9596","1549-960X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemical Information and Modeling","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069541378","display_name":"Elodie Lescot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Elodie Lescot","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091469186","display_name":"Ronan Bureau","orcid":"https://orcid.org/0000-0001-9404-8117","observed_orcids":["https://orcid.org/0000-0001-9404-8117"]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Ronan Bureau","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079656256","display_name":"Jana Sopkov\u00e1\u2010de Oliveira Santos","orcid":"https://orcid.org/0000-0002-4829-8120","observed_orcids":["https://orcid.org/0000-0002-4829-8120"]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jana Sopkova-de Oliveira Santos","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018243857","display_name":"Christophe Rochais","orcid":"https://orcid.org/0000-0001-7996-2082","observed_orcids":["https://orcid.org/0000-0001-7996-2082"]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Rochais","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033690493","display_name":"Vincent Lisowski","orcid":"https://orcid.org/0000-0002-4474-4242","observed_orcids":["https://orcid.org/0000-0002-4474-4242"]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Vincent Lisowski","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111725560","display_name":"Jean\u2010Charles Lancelot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Charles Lancelot","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113468466","display_name":"Sylvain Rault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392021217","display_name":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie","ror":"https://ror.org/012jsqx30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210105918","https://openalex.org/I4392021217","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sylvain Rault","raw_affiliation_strings":["Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre d'Etudes et de Recherche sur le M\u00e9dicament de Normandie, Universit\u00e9 de Basse-Normandie, 5, rue Vaub\u00e9nard, 14032 Caen, France","institution_ids":["https://openalex.org/I4392021217"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5091469186"],"corresponding_institution_ids":["https://openalex.org/I4392021217"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.4841,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.79847054,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"45","issue":"3","first_page":"708","last_page":"715"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gsk-3beta-inhibitors","display_name":"GSK-3\u03b2 inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/3d-qsar","display_name":"3D-QSAR","score":0.8730000257492065},{"id":"https://openalex.org/keywords/comfa","display_name":"CoMFA","score":0.9900000095367432},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.6370000243186951},{"id":"https://openalex.org/keywords/ligand-receptor-interactions","display_name":"ligand-receptor interactions","score":0.8849999904632568},{"id":"https://openalex.org/keywords/active-site-orientation","display_name":"active site orientation","score":0.6510000228881836},{"id":"https://openalex.org/keywords/co-crystal-structure","display_name":"co-crystal structure","score":0.6150000095367432},{"id":"https://openalex.org/keywords/lead-compound-design","display_name":"lead compound design","score":0.3370000123977661}],"concepts":[{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.7960917949676514},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.769528865814209},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6296640634536743},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.6132659316062927},{"id":"https://openalex.org/C2780283098","wikidata":"https://www.wikidata.org/wiki/Q4688960","display_name":"Affinities","level":2,"score":0.6078784465789795},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.5598000884056091},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.5303006172180176},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.47946441173553467},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.4613852798938751},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.45937666296958923},{"id":"https://openalex.org/C3018795828","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Binding affinities","level":3,"score":0.4156127870082855},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.3568875789642334},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3374615013599396},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15597352385520935},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.09560048580169678},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09541213512420654},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.04927733540534973},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071679","descriptor_name":"Glycogen Synthase Kinase 3 beta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D038362","descriptor_name":"Glycogen Synthase Kinase 3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D038362","descriptor_name":"Glycogen Synthase Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/ci050008y","doi":"https://doi.org/10.1021/ci050008y","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ci050008y","pdf_url":null,"source":{"id":"https://openalex.org/S167262187","display_name":"Journal of Chemical Information and Modeling","issn_l":"1549-9596","issn":["1549-9596","1549-960X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemical Information and Modeling","raw_type":"journal-article"},{"id":"pmid:15921460","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15921460","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of chemical information and modeling","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320329938","display_name":"R\u00e9gion Normandie","ror":"https://ror.org/03cq89j92"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1533988144","https://openalex.org/W1650504959","https://openalex.org/W1972343960","https://openalex.org/W1976499671","https://openalex.org/W1982958012","https://openalex.org/W1992522853","https://openalex.org/W2005766257","https://openalex.org/W2007798373","https://openalex.org/W2027408247","https://openalex.org/W2030093162","https://openalex.org/W2046092680","https://openalex.org/W2050456292","https://openalex.org/W2058138221","https://openalex.org/W2083308747","https://openalex.org/W2104373322","https://openalex.org/W2154046401","https://openalex.org/W2155836103","https://openalex.org/W2156118208","https://openalex.org/W2160003033","https://openalex.org/W2161239029","https://openalex.org/W2178382797"],"related_works":["https://openalex.org/W2027370145","https://openalex.org/W2011291938","https://openalex.org/W1576965855","https://openalex.org/W2058268466","https://openalex.org/W1487058108","https://openalex.org/W2130326292","https://openalex.org/W2050509097","https://openalex.org/W2012531135","https://openalex.org/W2591788703","https://openalex.org/W4411822706"],"abstract_inverted_index":{"The":[0,19,36],"three-dimensional":[1],"structures":[2],"of":[3,22,38,60,64,98],"3-anilino-4-arylmaleimides,":[4],"selective":[5],"GSK-3beta":[6,23,78],"inhibitors,":[7],"were":[8,70],"correlated":[9],"to":[10,28,32,46,74,93],"their":[11],"biological":[12,115],"affinities":[13],"by":[14],"3D-QSAR":[15,30],"studies":[16,69],"(CoMFA":[17],"method).":[18],"cocrystallographic":[20],"data":[21],"vs":[24],"3-anilino-4-arylmaleimide":[25,111],"allowed":[26,91],"us":[27,92],"compare":[29],"results":[31,37],"experimental":[33],"intermolecular":[34],"interactions.":[35],"the":[39,47,51,61,65,71,102,106,109],"CoMFA":[40],"analysis":[41],"did":[42],"not":[43],"really":[44],"correspond":[45],"interactions":[48,66],"recorded":[49],"in":[50],"active":[52,62,103],"site,":[53,104],"but":[54],"they":[55],"characterized":[56],"fundamental":[57],"features":[58],"(areas":[59],"site)":[63],"ligand-receptor.":[67],"These":[68],"starting":[72],"point":[73],"analyze":[75],"a":[76,80],"new":[77],"ligand,":[79],"thieno[2,3-b]pyrrolizinone":[81],"derivative.":[82],"This":[83],"comparison":[84],"based":[85],"on":[86],"docking":[87],"and":[88,113],"simulation":[89],"approaches":[90],"confirm":[94],"one":[95],"preferential":[96],"orientation":[97],"this":[99],"ligand":[100],"inside":[101],"explaining":[105],"relationship":[107],"with":[108],"reference":[110],"derivatives":[112],"its":[114],"affinity.":[116]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}